The Fact.MR study on cancer immunotherapy market offers detailed analysis on the key growth drivers and trends affecting demand in the market.
Valuation of US$ 310 Billion to be Acquired by Cancer Immunotherapy Market: Exclusive Report by Fact.MR
The Fact.MR study on cancer immunotherapy market offers detailed analysis on the key growth drivers and trends affecting demand in the market. The survey also provides insights into the competitive landscape, identifying the key market players and analyzing the impact of their growth strategies.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global cancer immunotherapy market projects robust growth outlook over the forecast period of 2021-2031. By the course of the assessment period 2021-2031, the market is estimated to have surpassed US$ 310 billion, with an astounding CAGR of 10%.
The relevance of disseminating effective cancer therapy techniques is being recognized by prominent regulatory authorities. As a result, both governments and healthcare institutions are increasing their spending on healthcare. The cancer immunotherapy industry is predicted to grow as a result of the aforementioned factors.
According to the International Agency for Research on Cancer, there would be 19.3 million new cancer cases in 2020, excluding 18.1 million non-melanoma skin cancer cases, and about 10 million fatalities (9.9 million removing non-melanoma deaths). With an expected 11.7% new cases, female breast cancer has surpassed lung cancer as the most often diagnosed cancer in women.
Want A Detailed Understanding of Market Functioning? Request for a Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=4367
In 2040, the global burden is expected to reach 28.4 million cases, up 47% from 2020. As a result, efforts to create a long-term infrastructure for disseminating cancer prevention and diagnostics have become important in order to achieve a global reduction in cancer rates. As a result, immuno-oncology is gaining in popularity with each passing day.
Lung cancer is the most prevalent cancer diagnosed in people, aside from prostate cancer in men and breast cancer in women. Furthermore, lung cancer is less likely to be discovered at an early stage. As a result, the number of people with lung cancer who do not receive effective treatment has increased. As a result, patients have begun to rely on cancer immunotherapy.
“Manufacturers are focusing on developing anticancer drugs, particularly for lung cancer, given the influence of the multitude of drivers adversely impacting the health of lungs. This, in turn, is expected augment demand for cancer immunotherapy,” states a Fact.MR analyst.
Key Takeaways:
- Lung cancer is predicted to account for more than half of the market share for cancer immunotherapy.
- In the forecast period 2021-2031, Asia is expected to grow at a CAGR of 10%.
- North America is expected to hold over 40% of market share for cancer immunotherapy.
- High preference for monoclonal antibodies-based cancer immunotherapy, with a CAGR of 9% projected through 2031.
- Hospitals will be the key cancer immunotherapy end user, accounting for 61% of market demand.
Growth Drivers:
- Increased spending on healthcare by governments and healthcare institutions to provide an impetus to the immuno-oncology market.
- Rise in number of patients diagnosed with cancer to propel the demand of cancer immunotherapy.
Key Restrains:
- Drug rejection is a challenge to manufacturers since cancer is a difficult condition to treat, and rejection wastes resources.
- As merely 5% of anticancer drugs attain commercial license post Phase III trials, the investment in experiments and clinical trials can cause loses. Therefore, hampering the market growth.
To learn more about Cancer Immunotherapy Market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4367
Competitive Landscape:
Extensive clinical trials are being used by major market companies to validate the efficiency of various immunotherapy techniques, such as vaccines and oral medicines. In addition, players are sponsoring more research studies to determine cancer prevalence patterns across major areas.
- In September 2021, AstraZeneca PLC addressed the possibility of developing a cancer vaccine using the same technology that was used to develop the COVID-19 vaccine.
- Similarly, In September 2021, Bristol-Myers Squibb Company performed a poll that included 250 oncologists, surgeons, and specialists from the United States, Germany, and Japan. The results of the survey highlighted the possibility of immunotherapy for tumors that are discovered early on.
Key companies profiled by Fact.MR are:
- Amgen Inc.
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Eli Lilly and Company
- GlaxoSmithKline Plc.
- F. Hoffmann-La Roche Ltd.
- Janssen Biotech, Inc.
- Novartis AG
- Merck & Co., Inc.
- Pfizer, Inc.
- Spectrum Pharmaceuticals, Inc.
- Sanofi
- Takeda Pharmaceuticals
More Insights on the Cancer Immunotherapy Market:
Fact.MR provides an unbiased analysis of the cancer immunotherapy market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global cancer immunotherapy market with a detailed segmentation on the basis of:
Therapy
- Monoclonal Antibodies
- Immune Checkpoint Inhibitors
- PD-1/PD-L1
- CTLA-4
- Immune System Modulators
- Cancer Vaccines
- Others
Cancer Type
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Melanoma
- Blood Cancer
- Others
End User
- Hospitals
- Ambulatory Surgical Centres
- Cancer Research Centres
- Clinics
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Questions Covered in the Cancer Immunotherapy Market Report
- The report offers detailed insights into cancer immunotherapy demand outlook for 2021-2031.
- The market study also highlights projected sales growth for cancer immunotherapy market between 2021 and 2031.
- Cancer immunotherapy market survey identifies key growth drivers, restrains, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry.
- Cancer immunotherapy market share analysis of the key companies within the industry and coverage of strategies such as mergers and acquisitions, joint ventures, collaborations or partnerships, and others.
Explore Fact.MR’s Coverage on the Healthcare Domain -
Cancer Therapeutics Market Forecast - Discoveries of revolutionary peptide-based medications are projected to influence developing trends in the cancer therapeutics market, with the cancer therapeutics sector is steady in its R&D operations. In the future years, peptide-based drugs are projected to become more widely used in cancer therapeutics.
Cancer Biomarkers Market Analysis - Governments' aggressive funding initiatives for cancer diagnostics are expanding the market for cancer biomarkers. Demand for cancer biomarkers will be bolstered by factors such as the availability of low-cost, non-invasive prognosis.
Cancer Profiling Market Scope - The global cancer profiling market is predicted to grow significantly between now and 2021, as the demand for precision medicine and high-quality oncology care grows.
Early-Stage Lung Cancer Diagnostics Market Insights - Increasing prevalence of leukemia and prostate cancer with increased funding by governments for the development of novel therapies for the treatment of cancer to drive the early-stage lung cancer diagnostics market.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to chemical and materials, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our chemical and materials research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR